Diabetes
Findings from D. Singhfranco and Co-Authors Provide New Insights into Diabetes
Published in Obesity and Diabetes Week, March 21st, 2011
2011 MAR 21 -- "The objective of this systematic review and meta-analysis was to assess the effect of pramlintide on glycemic control, weight and incidence of nausea and hypoglycaemia in patients with type 2 diabetes mellitus (T2DM) and in obese patients without diabetes (OBP). Eight randomized, clinical trials were identified from multiple databases," scientists in the United States report.
"Qualitative assessments and quantitative analyses were performed. In four T2DM studies (N = 930,duration of studies 16-52weeks,120-150mcg/dose BID-TID), all patients received insulin therapy. In four obesity studies (N = 686,duration of studies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Integrative Biology
Data on Integrative Biology Described by I. Rudkowska et al - Diabetes
Findings from H.J. Moller et al in Diabetes Reported - Diabetes
Findings from Johns Hopkins University Advance Knowledge in Diabetes - Diabetes
Investigators at Brigham and Women's Hospital Release New Data on Diabetes - Diabetes
Investigators at University of California Have Published New Data on Diabetes - Diabetes
Investigators at Winthrop University Hospital Release New Data on Diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
